Study of the interactions between obesity, metabolic dysregulation, and mental disorders, with particular attention to the psychopathological, cognitive, and behavioral effects of excess body weight and to the impact of next-generation pharmacological treatments (e.g., incretin agonists and integrated strategies) in patients with and without psychiatric comorbidity.
Relevance Area: Clinical
Research Group:
Andrea Fagiolini, Alessandro Cuomo, Pietro Carmellini